Financial Gravity Asset Management, Inc. Amphastar Pharmaceuticals, Inc. Transaction History

Financial Gravity Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$45.51 - $65.0 $2,548 - $3,640	-56 Reduced 98.25%	1 $0
Q2 2023 Aug 08, 2023	BUY	$35.77 - $58.38 $2,038 - $3,327	57 New	57 $949,000
Q4 2022 Feb 15, 2023	SELL	$27.93 - $31.27 $11,730 - $13,133	-420 Reduced 93.75%	28 $760,000
Q3 2022 Nov 03, 2022	BUY	$27.56 - $37.75 $12,346 - $16,912	448 New	448 $2.11 Million
Q4 2019 Feb 28, 2020	SELL	$17.07 - $20.64 $358 - $433	-21 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$19.12 - $22.62 $286 - $339	-15 Reduced 41.67%	21 $0
Q2 2019 Jul 26, 2019	SELL	$18.92 - $22.96 $38,067 - $46,195	-2,012 Reduced 98.24%	36 $1,000
Q1 2019 Apr 19, 2019	BUY	$19.46 - $25.28 $39,854 - $51,773	2,048 New	2,048 $43,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.